Skip to main content
Top
Published in: BMC Immunology 1/2012

Open Access 01-12-2012 | Research article

Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells

Authors: Zohreh Tatari-Calderone, Milica Stojakovic, Ramita Dewan, Gama Le Bouder, Dragana Jankovic, Stanislav Vukmanovic

Published in: BMC Immunology | Issue 1/2012

Login to get access

Abstract

Background

Thymic involution is a prominent characteristic of an aging immune system. When thymic function is reduced/absent, the peripheral T cell pool is subject to the laws of peripheral T cell homeostasis that favor survival/expansion of T cell receptors with relatively higher functional avidity for self-peptide/MHC complexes. Due to difficulties in assessing the TCR avidity in polyclonal population of T cells, it is currently not known whether high avidity T cells preferentially survive in aging individuals, and what impact this might have on the function of the immune system and development of autoimmune diseases.

Results

The phenotype of T cells from aged mice (18-24 months) indicating functional TCR avidity (CD3 and CD5 expression) correlates with the level of preserved thymic function. In mice with moderate thymic output (> 30% of peripheral CD62Lhi T cells), T cells displayed CD3lowCD5hi phenotype characteristic for high functional avidity. In old mice with drastically low numbers of CD62Lhi T cells reduced CD5 levels were found. After adult thymectomy, T cells of young mice developed CD3lowCD5hi phenotype, followed by a CD3lowCD5low phenotype. Spleens of old mice with the CD3low/CD5hi T cell phenotype displayed increased levels of IL-10 mRNA, and their T cells could be induced to secrete IL-10 in vitro. In contrast, downmodulation of CD5 was accompanied with reduced IL-10 expression and impaired anti-CD3 induced proliferation. Irrespective of the CD3/CD5 phenotype, reduced severity of experimental allergic myelitis occurred in old mice. In MTB TCRβ transgenic mice that display globally elevated TCR avidity for self peptide/MHC, identical change patterns occurred, only at an accelerated pace.

Conclusions

These findings suggest that age-associated dysfunctions of the immune system could in part be due to functional erosion of T cells devised to protect the hosts from the prolonged exposure to T cells with high-avidity for self.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sadighi Akha AA, Miller RA: Signal transduction in the aging immune system. Curr Opin Immunol. 2005, 17: 486-491. 10.1016/j.coi.2005.07.004.PubMedCrossRef Sadighi Akha AA, Miller RA: Signal transduction in the aging immune system. Curr Opin Immunol. 2005, 17: 486-491. 10.1016/j.coi.2005.07.004.PubMedCrossRef
2.
go back to reference Miller RA: The aging immune system: primer and prospectus. Science. 1996, 273: 70-74. 10.1126/science.273.5271.70.PubMedCrossRef Miller RA: The aging immune system: primer and prospectus. Science. 1996, 273: 70-74. 10.1126/science.273.5271.70.PubMedCrossRef
3.
go back to reference Lerner A, Yamada T, Miller RA: Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur J Immunol. 1989, 19: 977-982. 10.1002/eji.1830190604.PubMedCrossRef Lerner A, Yamada T, Miller RA: Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur J Immunol. 1989, 19: 977-982. 10.1002/eji.1830190604.PubMedCrossRef
4.
go back to reference Miller RA, Garcia G, Kirk CJ, Witkowski JM: Early activation defects in T lymphocytes from aged mice. Immunol Rev. 1997, 160: 79-90. 10.1111/j.1600-065X.1997.tb01029.x.PubMedCrossRef Miller RA, Garcia G, Kirk CJ, Witkowski JM: Early activation defects in T lymphocytes from aged mice. Immunol Rev. 1997, 160: 79-90. 10.1111/j.1600-065X.1997.tb01029.x.PubMedCrossRef
5.
go back to reference Hirokawa K: Age-related changes of signal transduction in T cells. Exp Gerontol. 1999, 34: 7-18. 10.1016/S0531-5565(98)00067-9.PubMedCrossRef Hirokawa K: Age-related changes of signal transduction in T cells. Exp Gerontol. 1999, 34: 7-18. 10.1016/S0531-5565(98)00067-9.PubMedCrossRef
6.
go back to reference Grossmann A, Maggio-Price L, Jinneman JC, Rabinovitch PS: Influence of aging on intracellular free calcium and proliferation of mouse T-cell subsets from various lymphoid organs. Cell Immunol. 1991, 135: 118-131. 10.1016/0008-8749(91)90259-E.PubMedCrossRef Grossmann A, Maggio-Price L, Jinneman JC, Rabinovitch PS: Influence of aging on intracellular free calcium and proliferation of mouse T-cell subsets from various lymphoid organs. Cell Immunol. 1991, 135: 118-131. 10.1016/0008-8749(91)90259-E.PubMedCrossRef
7.
go back to reference Thoman ML, Weigle WO: Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol. 1981, 127: 2102-2106.PubMed Thoman ML, Weigle WO: Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol. 1981, 127: 2102-2106.PubMed
8.
go back to reference Linton PJ, Haynes L, Klinman NR, Swain SL: Antigen-independent changes in naive CD4 T cells with aging. J Exp Med. 1996, 184: 1891-1900. 10.1084/jem.184.5.1891.PubMedCrossRef Linton PJ, Haynes L, Klinman NR, Swain SL: Antigen-independent changes in naive CD4 T cells with aging. J Exp Med. 1996, 184: 1891-1900. 10.1084/jem.184.5.1891.PubMedCrossRef
9.
go back to reference Scollay RG, Butcher EC, Weissman IL: Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol. 1980, 10: 210-218. 10.1002/eji.1830100310.PubMedCrossRef Scollay RG, Butcher EC, Weissman IL: Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol. 1980, 10: 210-218. 10.1002/eji.1830100310.PubMedCrossRef
10.
go back to reference Metcalf D, Moulds R, Pike B: Influence of the spleen and thymus on immune responses in ageing mice. Clin Exp Immunol. 1967, 2: 109-120.PubMedPubMedCentral Metcalf D, Moulds R, Pike B: Influence of the spleen and thymus on immune responses in ageing mice. Clin Exp Immunol. 1967, 2: 109-120.PubMedPubMedCentral
11.
go back to reference Hartwig M, Steinmann G: On a causal mechanism of chronic thymic involution in man. Mech Ageing Dev. 1994, 75: 151-156. 10.1016/0047-6374(94)90083-3.PubMedCrossRef Hartwig M, Steinmann G: On a causal mechanism of chronic thymic involution in man. Mech Ageing Dev. 1994, 75: 151-156. 10.1016/0047-6374(94)90083-3.PubMedCrossRef
12.
go back to reference Kadish JL, Basch RS: Hematopoietic thymocyte precursors. I. Assay and kinetics of the appearance of progeny. J Exp Med. 1976, 143: 1082-1099. 10.1084/jem.143.5.1082.PubMedCrossRef Kadish JL, Basch RS: Hematopoietic thymocyte precursors. I. Assay and kinetics of the appearance of progeny. J Exp Med. 1976, 143: 1082-1099. 10.1084/jem.143.5.1082.PubMedCrossRef
13.
go back to reference Freitas AA, Rocha B: Population biology of lymphocytes: the flight for survival. Annu Rev Immunol. 2000, 18: 83-111. 10.1146/annurev.immunol.18.1.83.PubMedCrossRef Freitas AA, Rocha B: Population biology of lymphocytes: the flight for survival. Annu Rev Immunol. 2000, 18: 83-111. 10.1146/annurev.immunol.18.1.83.PubMedCrossRef
14.
go back to reference Mackall CL, Gress RE: Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev. 1997, 157: 61-72. 10.1111/j.1600-065X.1997.tb00974.x.PubMedCrossRef Mackall CL, Gress RE: Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev. 1997, 157: 61-72. 10.1111/j.1600-065X.1997.tb00974.x.PubMedCrossRef
15.
go back to reference Linton PJ, Dorshkind K: Age-related changes in lymphocyte development and function. Nat Immunol. 2004, 5: 133-139.PubMedCrossRef Linton PJ, Dorshkind K: Age-related changes in lymphocyte development and function. Nat Immunol. 2004, 5: 133-139.PubMedCrossRef
16.
go back to reference Ge Q, Rao VP, Cho BK, Eisen HN, Chen J: Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/MHC epitopes and strength of their interaction with T cell receptors. Proc Natl Acad Sci USA. 2001, 98: 1728-1733. 10.1073/pnas.98.4.1728.PubMedPubMedCentralCrossRef Ge Q, Rao VP, Cho BK, Eisen HN, Chen J: Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/MHC epitopes and strength of their interaction with T cell receptors. Proc Natl Acad Sci USA. 2001, 98: 1728-1733. 10.1073/pnas.98.4.1728.PubMedPubMedCentralCrossRef
17.
go back to reference Moses CT, Thorstenson KM, Jameson SC, Khoruts A: Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci USA. 2003, 100: 1185-1190. 10.1073/pnas.0334572100.PubMedPubMedCentralCrossRef Moses CT, Thorstenson KM, Jameson SC, Khoruts A: Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci USA. 2003, 100: 1185-1190. 10.1073/pnas.0334572100.PubMedPubMedCentralCrossRef
18.
go back to reference Kieper WC, Burghardt JT, Surh CD: A role for TCR affinity in regulating naive T cell homeostasis. J Immunol. 2004, 172: 40-44.PubMedCrossRef Kieper WC, Burghardt JT, Surh CD: A role for TCR affinity in regulating naive T cell homeostasis. J Immunol. 2004, 172: 40-44.PubMedCrossRef
19.
go back to reference Azzam HS, DeJarnette JB, Huang K, Emmons R, Park CS, Sommers CL, El-Khoury D, Shores EW, Love PE: Fine tuning of TCR signaling by CD5. J Immunol. 2001, 166: 5464-5472.PubMedCrossRef Azzam HS, DeJarnette JB, Huang K, Emmons R, Park CS, Sommers CL, El-Khoury D, Shores EW, Love PE: Fine tuning of TCR signaling by CD5. J Immunol. 2001, 166: 5464-5472.PubMedCrossRef
20.
go back to reference Smith K, Seddon B, Purbhoo MA, Zamoyska R, Fisher AG, Merkenschlager M: Sensory adaptation in naive peripheral CD4 T cells. J Exp Med. 2001, 194: 1253-1261. 10.1084/jem.194.9.1253.PubMedPubMedCentralCrossRef Smith K, Seddon B, Purbhoo MA, Zamoyska R, Fisher AG, Merkenschlager M: Sensory adaptation in naive peripheral CD4 T cells. J Exp Med. 2001, 194: 1253-1261. 10.1084/jem.194.9.1253.PubMedPubMedCentralCrossRef
21.
go back to reference Kassiotis G, Zamoyska R, Stockinger B: Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med. 2003, 197: 1007-1016. 10.1084/jem.20021812.PubMedPubMedCentralCrossRef Kassiotis G, Zamoyska R, Stockinger B: Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med. 2003, 197: 1007-1016. 10.1084/jem.20021812.PubMedPubMedCentralCrossRef
22.
go back to reference Perez-Villar JJ, Whitney GS, Bowen MA, Hewgill DH, Aruffo AA, Kanner SB: CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol. 1999, 19: 2903-2912.PubMedPubMedCentralCrossRef Perez-Villar JJ, Whitney GS, Bowen MA, Hewgill DH, Aruffo AA, Kanner SB: CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol. 1999, 19: 2903-2912.PubMedPubMedCentralCrossRef
23.
go back to reference Stojakovic M, Salazar-Fontana LI, Tatari-Calderone Z, Badovinac VP, Santori FR, Kovalovsky D, Sant'Angelo D, Harty JT, Vukmanovic S: Adaptable TCR avidity thresholds for negative selection. J Immunol. 2008, 181: 6770-6778.PubMedCrossRef Stojakovic M, Salazar-Fontana LI, Tatari-Calderone Z, Badovinac VP, Santori FR, Kovalovsky D, Sant'Angelo D, Harty JT, Vukmanovic S: Adaptable TCR avidity thresholds for negative selection. J Immunol. 2008, 181: 6770-6778.PubMedCrossRef
24.
go back to reference Turner SJ, Doherty PC, McCluskey J, Rossjohn J: Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006, 6: 883-894. 10.1038/nri1977.PubMedCrossRef Turner SJ, Doherty PC, McCluskey J, Rossjohn J: Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006, 6: 883-894. 10.1038/nri1977.PubMedCrossRef
25.
go back to reference Zeh HJI, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC: High avidity CTLs for two self antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol. 1999, 162: 989-994.PubMed Zeh HJI, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC: High avidity CTLs for two self antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol. 1999, 162: 989-994.PubMed
26.
go back to reference Derby MA, Alexander-Miller MA, Tse R, Berzofsky JA: High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol. 2001, 166: 1690-1697.PubMedCrossRef Derby MA, Alexander-Miller MA, Tse R, Berzofsky JA: High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol. 2001, 166: 1690-1697.PubMedCrossRef
27.
go back to reference Holler PD, Chlewiski LK, Kranz DM: TCRs with high affinity for foreign pMHC show self reactivity. Nature Immunol. 2003, 4: 55-62. 10.1038/ni863.CrossRef Holler PD, Chlewiski LK, Kranz DM: TCRs with high affinity for foreign pMHC show self reactivity. Nature Immunol. 2003, 4: 55-62. 10.1038/ni863.CrossRef
28.
go back to reference Santori FR, Brown SM, Vukmanovic S: Genomics-based identification of self-ligands with T cell receptor-specific biological activity. Immunol Rev. 2002, 190: 146-160. 10.1034/j.1600-065X.2002.19011.x.PubMedCrossRef Santori FR, Brown SM, Vukmanovic S: Genomics-based identification of self-ligands with T cell receptor-specific biological activity. Immunol Rev. 2002, 190: 146-160. 10.1034/j.1600-065X.2002.19011.x.PubMedCrossRef
29.
go back to reference Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P: Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 2000, 406: 739-742. 10.1038/35021081.PubMedCrossRef Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P: Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 2000, 406: 739-742. 10.1038/35021081.PubMedCrossRef
30.
go back to reference Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES: Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Nat Acad Sci USA. 2001, 98: 6818-6823. 10.1073/pnas.111161198.PubMedPubMedCentralCrossRef Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES: Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Nat Acad Sci USA. 2001, 98: 6818-6823. 10.1073/pnas.111161198.PubMedPubMedCentralCrossRef
31.
go back to reference Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B: TCR affinity and negative regulation limit autoimmunity. Nat Med. 2004, 10: 1234-1239. 10.1038/nm1114.PubMedCrossRef Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B: TCR affinity and negative regulation limit autoimmunity. Nat Med. 2004, 10: 1234-1239. 10.1038/nm1114.PubMedCrossRef
32.
go back to reference Han B, Serra P, Yamanouchi J, Amrani A, Elliott J, Dickie P, Dilorenzo T, Santamaria P: Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest. 2005, 115: 1879-1887. 10.1172/JCI24219.PubMedPubMedCentralCrossRef Han B, Serra P, Yamanouchi J, Amrani A, Elliott J, Dickie P, Dilorenzo T, Santamaria P: Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest. 2005, 115: 1879-1887. 10.1172/JCI24219.PubMedPubMedCentralCrossRef
33.
go back to reference Li L, Boussiotis VA: Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. J Mol Med. 2006, 84: 887-899. 10.1007/s00109-006-0098-5.PubMedCrossRef Li L, Boussiotis VA: Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. J Mol Med. 2006, 84: 887-899. 10.1007/s00109-006-0098-5.PubMedCrossRef
34.
go back to reference Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A: Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II restricted T cells anergized in vivo. J Exp Med. 1988, 187: 177-183.CrossRef Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A: Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II restricted T cells anergized in vivo. J Exp Med. 1988, 187: 177-183.CrossRef
35.
go back to reference Sundstedt A, Hoiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M: Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol. 1997, 158: 180-186.PubMed Sundstedt A, Hoiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M: Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol. 1997, 158: 180-186.PubMed
36.
go back to reference Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC: Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol. 1999, 11: 1625-1634. 10.1093/intimm/11.10.1625.PubMedCrossRef Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC: Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol. 1999, 11: 1625-1634. 10.1093/intimm/11.10.1625.PubMedCrossRef
37.
go back to reference Seewaldt S, Alferink J, Forster I: Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur J Immunol. 2002, 32: 3607-3616. 10.1002/1521-4141(200212)32:12<3607::AID-IMMU3607>3.0.CO;2-O.PubMedCrossRef Seewaldt S, Alferink J, Forster I: Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur J Immunol. 2002, 32: 3607-3616. 10.1002/1521-4141(200212)32:12<3607::AID-IMMU3607>3.0.CO;2-O.PubMedCrossRef
38.
go back to reference Starr TK, Jameson SC, Hogquist KA: Positive and negative selection of T cells. Annu Rev Immunol. 2003, 21: 139-176. 10.1146/annurev.immunol.21.120601.141107.PubMedCrossRef Starr TK, Jameson SC, Hogquist KA: Positive and negative selection of T cells. Annu Rev Immunol. 2003, 21: 139-176. 10.1146/annurev.immunol.21.120601.141107.PubMedCrossRef
39.
go back to reference Palmer E: The T-cell antigen receptor: a logical response to an unknown ligand. J Recept Signal Transduct Res. 2006, 26: 367-378. 10.1080/10799890600919094.PubMedCrossRef Palmer E: The T-cell antigen receptor: a logical response to an unknown ligand. J Recept Signal Transduct Res. 2006, 26: 367-378. 10.1080/10799890600919094.PubMedCrossRef
40.
go back to reference Vukmanovic S, Neubert TA, Santori FR: Could TCR antagonism explain associations between MHC genes and disease?. Trends Mol Med. 2003, 9: 139-146. 10.1016/S1471-4914(03)00029-7.PubMedCrossRef Vukmanovic S, Neubert TA, Santori FR: Could TCR antagonism explain associations between MHC genes and disease?. Trends Mol Med. 2003, 9: 139-146. 10.1016/S1471-4914(03)00029-7.PubMedCrossRef
41.
go back to reference Jameson SC: T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol. 2005, 17: 231-237. 10.1016/j.smim.2005.02.003.PubMedCrossRef Jameson SC: T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol. 2005, 17: 231-237. 10.1016/j.smim.2005.02.003.PubMedCrossRef
42.
go back to reference Jabbari A, Harty JT: Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation. J Immunol. 2005, 175: 4829-4833.PubMedCrossRef Jabbari A, Harty JT: Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation. J Immunol. 2005, 175: 4829-4833.PubMedCrossRef
43.
go back to reference Oehen S, Brduscha-Riem K: Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies?. EurJImmunol. 1999, 29: 608-614. Oehen S, Brduscha-Riem K: Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies?. EurJImmunol. 1999, 29: 608-614.
44.
go back to reference Kieper WC, Jameson SC: Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA. 1999, 96: 13306-13311. 10.1073/pnas.96.23.13306.PubMedPubMedCentralCrossRef Kieper WC, Jameson SC: Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA. 1999, 96: 13306-13311. 10.1073/pnas.96.23.13306.PubMedPubMedCentralCrossRef
45.
go back to reference Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. JExpMed. 2000, 192: 557-564. 10.1084/jem.192.4.557.CrossRef Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. JExpMed. 2000, 192: 557-564. 10.1084/jem.192.4.557.CrossRef
46.
go back to reference Cho BK, Rao VP, Ge Q, Eisen HN, Chen J: Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. JExpMed. 2000, 192: 549-556. 10.1084/jem.192.4.549.CrossRef Cho BK, Rao VP, Ge Q, Eisen HN, Chen J: Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. JExpMed. 2000, 192: 549-556. 10.1084/jem.192.4.549.CrossRef
47.
go back to reference Murali-Krishna K, Ahmed R: Cutting edge: naive T cells masquerading as memory cells. J Immunol. 2000, 165: 1733-1737.PubMedCrossRef Murali-Krishna K, Ahmed R: Cutting edge: naive T cells masquerading as memory cells. J Immunol. 2000, 165: 1733-1737.PubMedCrossRef
48.
go back to reference Baccala R, Theofilopoulos AN: The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol. 2005, 26: 5-8. 10.1016/j.it.2004.11.006.PubMedCrossRef Baccala R, Theofilopoulos AN: The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol. 2005, 26: 5-8. 10.1016/j.it.2004.11.006.PubMedCrossRef
49.
go back to reference Hochberg MC: The epidemiology of systemic lupus erythematosus. Dubois' Lupus Erythematosus. Edited by: Wallace DJ, Hahn BH. 1997, Baltimore: Williams & Wilkins, 49- Hochberg MC: The epidemiology of systemic lupus erythematosus. Dubois' Lupus Erythematosus. Edited by: Wallace DJ, Hahn BH. 1997, Baltimore: Williams & Wilkins, 49-
50.
go back to reference Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989, 112: 1419-1428. 10.1093/brain/112.6.1419.PubMedCrossRef Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989, 112: 1419-1428. 10.1093/brain/112.6.1419.PubMedCrossRef
51.
go back to reference Castle SC: Clinical relevance of age-related immune dysfunction. Clin Inf Dis. 2000, 31: 578-585. 10.1086/313947.CrossRef Castle SC: Clinical relevance of age-related immune dysfunction. Clin Inf Dis. 2000, 31: 578-585. 10.1086/313947.CrossRef
52.
go back to reference Stojakovic M, Tatari-Calderone Z, Maric C, Hoang A, Vukmanovic S: Paradoxical arrest in lupus activity in BXSB mice with highly autoreactive T cells. Lupus. 2010, 19: 182-191. 10.1177/0961203309350756.PubMedCrossRef Stojakovic M, Tatari-Calderone Z, Maric C, Hoang A, Vukmanovic S: Paradoxical arrest in lupus activity in BXSB mice with highly autoreactive T cells. Lupus. 2010, 19: 182-191. 10.1177/0961203309350756.PubMedCrossRef
53.
go back to reference Zepp J, Wu L, Li X: IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011, 32: 232-239. 10.1016/j.it.2011.02.007.PubMedPubMedCentralCrossRef Zepp J, Wu L, Li X: IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011, 32: 232-239. 10.1016/j.it.2011.02.007.PubMedPubMedCentralCrossRef
54.
go back to reference Astier AL, Meiffren G, Freeman S, Hafler DA: Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest. 2006, 116: 3252-3257. 10.1172/JCI29251.PubMedPubMedCentralCrossRef Astier AL, Meiffren G, Freeman S, Hafler DA: Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest. 2006, 116: 3252-3257. 10.1172/JCI29251.PubMedPubMedCentralCrossRef
55.
go back to reference Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B: IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol. 2008, 38: 576-586. 10.1002/eji.200737271.PubMedCrossRef Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B: IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol. 2008, 38: 576-586. 10.1002/eji.200737271.PubMedCrossRef
56.
go back to reference Hobb sMV, Weigle WO, Ernst DN: Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell Immunol. 1994, 154: 264-272. 10.1006/cimm.1994.1076.CrossRef Hobb sMV, Weigle WO, Ernst DN: Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell Immunol. 1994, 154: 264-272. 10.1006/cimm.1994.1076.CrossRef
57.
go back to reference Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993, 75: 263-274. 10.1016/0092-8674(93)80068-P.PubMedCrossRef Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993, 75: 263-274. 10.1016/0092-8674(93)80068-P.PubMedCrossRef
58.
go back to reference Groux H, Cottrez F: The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003, 20: 281-285. 10.1016/S0896-8411(03)00044-1.PubMedCrossRef Groux H, Cottrez F: The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003, 20: 281-285. 10.1016/S0896-8411(03)00044-1.PubMedCrossRef
59.
go back to reference Rott O, Fleischer B, Cash E: Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol. 1994, 24: 1434-1440. 10.1002/eji.1830240629.PubMedCrossRef Rott O, Fleischer B, Cash E: Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol. 1994, 24: 1434-1440. 10.1002/eji.1830240629.PubMedCrossRef
60.
go back to reference Nagelkerken L, Blauw B, Tielemans M: IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int Immunol. 1997, 9: 1243-1251. 10.1093/intimm/9.9.1243.PubMedCrossRef Nagelkerken L, Blauw B, Tielemans M: IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int Immunol. 1997, 9: 1243-1251. 10.1093/intimm/9.9.1243.PubMedCrossRef
61.
go back to reference Cannella B, Gao YL, Brosnan C, Raine CS: IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res. 1996, 45: 735-746. 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V.PubMedCrossRef Cannella B, Gao YL, Brosnan C, Raine CS: IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res. 1996, 45: 735-746. 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V.PubMedCrossRef
62.
go back to reference Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK: IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 1998, 161: 3299-3306.PubMed Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK: IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 1998, 161: 3299-3306.PubMed
63.
go back to reference Segal BM, Dwyer BK, Shevach EM: An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 1998, 187: 537-546. 10.1084/jem.187.4.537.PubMedPubMedCentralCrossRef Segal BM, Dwyer BK, Shevach EM: An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 1998, 187: 537-546. 10.1084/jem.187.4.537.PubMedPubMedCentralCrossRef
64.
go back to reference Samoilova EB, Horton JL, Chen Y: Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell Immunol. 1998, 188: 118-124. 10.1006/cimm.1998.1365.PubMedCrossRef Samoilova EB, Horton JL, Chen Y: Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell Immunol. 1998, 188: 118-124. 10.1006/cimm.1998.1365.PubMedCrossRef
65.
go back to reference Beebe AM, Cua DJ, de Waal Malefyt R: The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 2002, 13: 403-412. 10.1016/S1359-6101(02)00025-4.PubMedCrossRef Beebe AM, Cua DJ, de Waal Malefyt R: The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 2002, 13: 403-412. 10.1016/S1359-6101(02)00025-4.PubMedCrossRef
66.
go back to reference Llorente L, Richaud-Patin Y, García-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcón-Segovia D, Wijdenes J: Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 2000, 43: 1790-1800. 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2.PubMedCrossRef Llorente L, Richaud-Patin Y, García-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcón-Segovia D, Wijdenes J: Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 2000, 43: 1790-1800. 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2.PubMedCrossRef
67.
go back to reference Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994, 179: 305-310. 10.1084/jem.179.1.305.PubMedCrossRef Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994, 179: 305-310. 10.1084/jem.179.1.305.PubMedCrossRef
68.
go back to reference Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J: IL-10 regulates murine lupus. J Immunol. 2002, 169: 2148-2155.PubMedCrossRef Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J: IL-10 regulates murine lupus. J Immunol. 2002, 169: 2148-2155.PubMedCrossRef
69.
go back to reference Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L: IL-10 regulation of lupus in the NZM2410 murine model. Lab Investig. 2006, 86: 1136-1148.PubMed Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L: IL-10 regulation of lupus in the NZM2410 murine model. Lab Investig. 2006, 86: 1136-1148.PubMed
70.
go back to reference Ely KH, Roberts AD, Kohlmeier JE, Blackman MA, Woodland DL: Aging and CD8+ T cell immunity to respiratory virus infections. Exp Gerontol. 2007, 42: 427-431. 10.1016/j.exger.2006.11.017.PubMedPubMedCentralCrossRef Ely KH, Roberts AD, Kohlmeier JE, Blackman MA, Woodland DL: Aging and CD8+ T cell immunity to respiratory virus infections. Exp Gerontol. 2007, 42: 427-431. 10.1016/j.exger.2006.11.017.PubMedPubMedCentralCrossRef
71.
go back to reference Janicki CN, Jenkinson SR, Williams NA, Morgan DJ: Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. Cancer Res. 2008, 68: 2993-3000. 10.1158/0008-5472.CAN-07-5008.PubMedCrossRef Janicki CN, Jenkinson SR, Williams NA, Morgan DJ: Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. Cancer Res. 2008, 68: 2993-3000. 10.1158/0008-5472.CAN-07-5008.PubMedCrossRef
72.
go back to reference Santori FR, Popmihajlov Z, Badovinac VP, Smith C, Radoja S, Harty JT, Vukmanovic S: TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex. J Immunol. 2007, 178: 6109-6114.PubMedCrossRef Santori FR, Popmihajlov Z, Badovinac VP, Smith C, Radoja S, Harty JT, Vukmanovic S: TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex. J Immunol. 2007, 178: 6109-6114.PubMedCrossRef
73.
go back to reference Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y: Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol. 1999, 163: 2937-2943.PubMed Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y: Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol. 1999, 163: 2937-2943.PubMed
74.
go back to reference Oliver AR, Lyon GM, Ruddle NH: Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol. 2003, 171: 462-468.PubMedCrossRef Oliver AR, Lyon GM, Ruddle NH: Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol. 2003, 171: 462-468.PubMedCrossRef
Metadata
Title
Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells
Authors
Zohreh Tatari-Calderone
Milica Stojakovic
Ramita Dewan
Gama Le Bouder
Dragana Jankovic
Stanislav Vukmanovic
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2012
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-13-8

Other articles of this Issue 1/2012

BMC Immunology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine